Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial. - Kikawa Y; Uemura Y; Taira T; Kitagawa C; Maeda H; Kato H; Hashimoto N; Hosoda M; Hamanaka Y; Tanabe Y; Yoshida T; Tane K; et al. (JAMA network open, 2025)